Showing results (321-330 of 528) with videos related to
Sort By:
Pageof 53
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.Plos One|September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trialCristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillanceBrandi Freeman, Sandra Lester, Lisa Mills, et al.Nature Communications|August 2, 2022
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newbornsSimon D van Haren, Gabriel K Pedersen, Azad Kumar, et al.Plos One|April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adultsMichelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.Cell Reports|September 26, 2019
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTDNianshuang Wang, Osnat Rosen, Lingshu Wang, et al.Vaccine|October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy UgandansMichael A Eller, Leigh Anne Eller, Marc S Opollo, et al.Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.Science Translational Medicine|March 4, 2021
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primatesNicole Darricarrère, Yu Qiu, Masaru Kanekiyo, et al.The Lancet. Healthy Longevity|September 13, 2022
Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge modelStephanie Ascough, Pete Dayananda, Mohini Kalyan, et al.Pageof 53